This title provides an evidence-based approach to third- and fourth-line dermatologic therapies as well as to standard approaches. Although common diseases, such as psoriasis and eczema are covered, the book emphasizes therapeutically difficult diseases. It is organized by disease and briefly reviews diagnostic criteria before covering the first-, second-, third-, and fourth-line therapies. Within each therapeutic level, the therapies are ranked by efficacy and supporting evidence. This is an innovative book that combines evidence-based medicine with an easily accessible format.
- Fully covers treatment of 250 diseases, both common and therapeutically awkward, providing all the dermatologist needs in one volume.
- Covers all the therapeutic options, even third and fourth-line therapies - try this when all else fails.
- Organized alphabetically by disease and in an accessible tabular format for quick reference.
- Takes an evidence-based approach acknowledging anecdote as such, giving you the hard information that you need to make therapeutic decisions.
- Each chapter written to a template - you'll know your way around this text in no time.
- Full-color, key clinical photo of each disease giving the most accurate representation of a disease possible.
- Logically organized , with checklists of diagnostic and investigative pearls helping you to quickly verify that your diagnosis is correct.
- A summary of each treatment option, before detailed discussion, allows you to quickly refresh your knowledge when in a hurry.
- Editors offer their expert commentary on each treatment strategy.
- The references are annotated immediately providing information which would normally have to be sought on Medline.
- International team (25% European) of 250 experts present treatment options from all over the globe.
- The perfect companion wherever you practice - American drug names are given first, with European names in brackets afterwards. Also included: a full, international drug name glossary.
- The text is extensively cross-referenced avoiding duplication of information about drugs under several different diagnoses.
- Includes a modern, evidence-based /bilateral controlled-trial approach so you know what's anecdote and what is received fact.
